XML 36 R25.htm IDEA: XBRL DOCUMENT

Item 5. Other Information	3 Months Ended
Item 5. Other Information	Mar. 31, 2024
Nonmonetary Transactions [Abstract]
Document Information	ITEM 5. OTHER INFORMATION Update to Previously Reported Results On April 23, 2024, the Company issued a press release announcing its financial results for the first quarter ended March 31, 2024 (the “Earnings Press Release”). In the Earnings Press Release, the Company reported $32.5 million of net loan discount accretion for the three months ended March 31, 2024 related primarily to the accretion of fair value discounts on loans acquired in the recent transformational merger between the Company and PacWest Bancorp. While completing its review procedures for the preparation of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024, the Company identified an error in its previously reported amount of net loan discount accretion and, accordingly, adjusted its net loan discount accretion for the three months ended March 31, 2024 to $22.4 million. As a result, the Company also adjusted net earnings from $38.1 million to $30.9 million, diluted earnings per share from $0.17 to $0.12, and adjusted diluted earnings per share from $0.19 to $0.15 (see "Non-GAAP Financial Measures"). The Company determined that there was a data boarding issue in the Company’s loan servicing system related to acquired loans with terminal balloon payments which impacted the accretion calculation of fair value discounts. This data boarding issue resulted in a higher net loan discount accretion for those loans for the three months ended March 31, 2024. Upon identifying this issue, the Company engaged a nationally recognized accounting firm to assist it in completing a revised calculation of the net loan discount accretion for these loans. The information in this Form 10-Q amends and supersedes the disclosures in the Earnings Press Release. Trading Arrangements During the quarter ended March 31, 2024, none of our directors or executive officers adopted or terminated a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (in each case, as defined in Item 408 of Regulation S-K) for the purchase or sale of the Company’s securities.